ImmuCell Corp (NASDAQ:ICCC)

6.31
Delayed Data
As of Apr 24
 +0.06 / +0.96%
Today’s Change
3.30
Today|||52-Week Range
7.22
+29.84%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.25
Today’s open6.16
Day’s range-- - --
Volume12,660
Average volume (3 months)4,717
Market cap$19.1M
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)-250.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+26.46%
P/E ratioNM
Price/Sales1.94
Price/Book2.06

Competitors

 Today’s
change
Today’s
% change
RXIIRxi Pharmaceuticals ...-0.05-6.72%
CBMXCombiMatrix Corp+0.01+0.55%
CANFCan Fite Biopharma L...+0.02+0.93%
RGBPRegen BioPharma Inc+0.01+5.33%
Data as of 3:59pm ET, 04/24/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$7.6M
Annual profit (last year)-$167.2K
Net profit margin-2.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers